A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.
Korde N et al. Haematologica. 2014 Mar 21. [Epub ahead of print].

Sotatercept in patients with osteolytic lesions of multiple myeloma.
Abdulkadyrov KM et al. Br J Haematol. 2014 Mar 21. doi: 10.1111/bjh.12835. [Epub ahead of print].

Evolution of carfilzomib dose and schedule in patients with multiple myeloma: A historical overview.
Jakubowiak AJ. Cancer Treat Rev. 2014 Mar 1. pii: S0305-7372(14)00025-5. doi: 10.1016/j.ctrv.2014.02.005. [Epub ahead of print].

A case of ‘carfilzomib’ induced flash pulmonary edema.
Chadha S et al. Chest. 2014 Mar 1;145(3 Suppl):67A. doi: 10.1378/chest.1782952